New US Tariffs Push Indian Drugmakers to Move Production to America

Washington, Wednesday, 22 July 2026.
President Trump’s new tariffs, rising to 200% by 2029, pressure Indian drugmakers to onshore production. India currently supplies nearly half of all US generic prescriptions.